IPG Health debuts new clinical trial diversity approach based on experience and spurred by pharma requests
IPG Health is aiming to boost the call for more diversity in clinical trials with a new multi-disciplinary approach for pharma clients.
Based on its years of health equity experience — including its ongoing “Trial for #ClinicalEquality” campaign — the pharma and healthcare agency’s latest offering aims to address the gap between the desire for diversity in clinical trials and the real-world lack of it. Pharma clients have approached the agency, noting its pro bono work and accumulated expertise, to ask for help with their own efforts.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.